{"id":5769,"date":"2026-02-11T03:02:36","date_gmt":"2026-02-11T03:02:36","guid":{"rendered":"https:\/\/www.sutyo.com\/ruanda-biontechin-afrikadaki-ilk-asi-uretim-tesisini-acti\/"},"modified":"2026-02-11T03:02:36","modified_gmt":"2026-02-11T03:02:36","slug":"ruanda-biontechin-afrikadaki-ilk-asi-uretim-tesisini-acti","status":"publish","type":"post","link":"https:\/\/www.sutyo.com\/tr\/ruanda-biontechin-afrikadaki-ilk-asi-uretim-tesisini-acti\/","title":{"rendered":"Ruanda, Biontech\u2019in Afrika\u2019daki \u0130lk A\u015f\u0131 \u00dcretim Tesisini A\u00e7t\u0131"},"content":{"rendered":"<div>\n<p><strong>Alman biyoteknoloji \u015firketi BioNTech<\/strong>, <strong>18 Aral\u0131k Pazartesi<\/strong> g\u00fcn\u00fc, <strong>mRNA a\u015f\u0131lar\u0131n\u0131n \u00fcretimini kolayla\u015ft\u0131rma<\/strong> \u00e7abalar\u0131n\u0131n bir par\u00e7as\u0131 olarak <strong>Afrika\u2019daki ilk tesisini Ruanda\u2019n\u0131n ba\u015fkenti Kigali\u2019de<\/strong> hizmete a\u00e7t\u0131.<\/p>\n<p><strong>Kigali \u00d6zel Ekonomik B\u00f6lgesi\u2019nde<\/strong>, <strong>Gasabo B\u00f6lgesi<\/strong> s\u0131n\u0131rlar\u0131 i\u00e7inde, <strong>biyofarmas\u00f6tik \u00fcretime ayr\u0131lm\u0131\u015f bir alanda<\/strong> yer alan tesis, <strong>yakla\u015f\u0131k 300.000 metrekarelik<\/strong> bir alan\u0131 kaps\u0131yor. <strong>Tam kapasiteye ula\u015ft\u0131\u011f\u0131nda en az 100 ki\u015fiye istihdam<\/strong> sa\u011flayacak.<\/p>\n<p>A\u00e7\u0131l\u0131\u015fa, <strong>Devlet Ba\u015fkan\u0131 Paul Kagame<\/strong> ve <strong>First Lady Jeannette Kagame<\/strong>\u2019nin yan\u0131 s\u0131ra, <strong>Afrika\u2019dan ve d\u00fcnyan\u0131n farkl\u0131 b\u00f6lgelerinden \u00e7ok say\u0131da devlet ve h\u00fck\u00fcmet ba\u015fkan\u0131<\/strong>, <strong>Afrika Birli\u011fi<\/strong>, <strong>Avrupa Birli\u011fi<\/strong>, <strong>D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6)<\/strong> ve <strong>D\u00fcnya Ticaret \u00d6rg\u00fct\u00fc (DT\u00d6)<\/strong>\u2019nden \u00fcst d\u00fczey yetkililer kat\u0131ld\u0131.<\/p>\n<p>A\u00e7\u0131l\u0131\u015fta konu\u015fan <strong>BioNTech Kurucu Orta\u011f\u0131 ve CEO\u2019su U\u011fur \u015eahin<\/strong>, \u015firketin <strong>2024 y\u0131l\u0131nda t\u00fcm in\u015faat \u00e7al\u0131\u015fmalar\u0131n\u0131 tamamlamay\u0131<\/strong> ve tesiste <strong>yerel, uzman personelin e\u011fitimine ba\u015flamay\u0131<\/strong> planlad\u0131\u011f\u0131n\u0131 s\u00f6yledi. <strong>mRNA do\u011frulama testlerinin ise 2025\u2019te ba\u015flat\u0131lmas\u0131<\/strong> \u00f6ng\u00f6r\u00fcl\u00fcyor.<\/p>\n<p>\u015eahin, tesisin ba\u015flang\u0131\u00e7ta <strong>iki BioNTainer<\/strong> ile donat\u0131laca\u011f\u0131n\u0131 belirtti:<\/p>\n<ul>\n<li>\n<p><strong>Biri mRNA \u00fcretimi<\/strong> i\u00e7in<\/p>\n<\/li>\n<li>\n<p><strong>Di\u011feri form\u00fcle edilmi\u015f d\u00f6kme ila\u00e7 \u00fcr\u00fcn\u00fc \u00fcretimi<\/strong> i\u00e7in<\/p>\n<\/li>\n<\/ul>\n<p>Bu <strong>BioNTainer\u2019lar\u0131n<\/strong>, <strong>Afrika Birli\u011fi \u00fcyesi \u00fclkelerin ihtiya\u00e7lar\u0131na y\u00f6nelik \u00e7e\u015fitli mRNA tabanl\u0131 a\u015f\u0131lar\u0131<\/strong> \u00fcretebilecek kapasitede olaca\u011f\u0131 ifade edildi. Bu kapsamda, <strong>Pfizer-BioNTech Covid-19 a\u015f\u0131s\u0131<\/strong> ile <strong>BioNTech\u2019in s\u0131tma ve t\u00fcberk\u00fcloz i\u00e7in geli\u015ftirme a\u015famas\u0131ndaki a\u015f\u0131lar\u0131<\/strong>, <strong>ba\u015far\u0131yla geli\u015ftirilip onaylanmalar\u0131 veya yetkilendirilmeleri halinde<\/strong>, \u00fcretim portf\u00f6y\u00fcne dahil edilebilecek.<\/p>\n<p><strong>\u201cAfrika, d\u00fcnyan\u0131n en ileri \u00fcretim tesislerinden birine sahip olacak. Bu BioNTainer\u2019lar her t\u00fcrl\u00fc mRNA a\u015f\u0131s\u0131n\u0131 \u00fcretebilecek,\u201d<\/strong> diyen \u015eahin, tesisin <strong>y\u0131ll\u0131k 50 milyon dozdan fazla<\/strong> a\u015f\u0131 \u00fcretebilece\u011fini; <strong>salg\u0131n d\u00f6nemlerinde veya klinik \u00e7al\u0131\u015fmalar i\u00e7in y\u0131ll\u0131k yakla\u015f\u0131k 10.000 doz<\/strong> \u00fcretim yap\u0131labilece\u011fini vurgulad\u0131.<\/p>\n<p><strong>\u201cHen\u00fcz hedefe ula\u015fmad\u0131k; \u00f6n\u00fcm\u00fczde yap\u0131lacak \u00e7ok i\u015f var, ancak net bir plan\u0131m\u0131z mevcut.\u201d<\/strong><\/p>\n<p>\u015eahin ayr\u0131ca, <strong>2024\u2019te in\u015faat\u0131n tamamlanmas\u0131n\u0131n ard\u0131ndan devreye alma ve yeterlilik s\u00fcre\u00e7lerinin ba\u015flat\u0131laca\u011f\u0131n\u0131<\/strong>, <strong>d\u00fczenleyici s\u00fcre\u00e7ler<\/strong>, <strong>kalite kontrol<\/strong> ve <strong>yerel personelin e\u011fitiminin<\/strong> \u00f6ncelik olaca\u011f\u0131n\u0131 belirtti.<strong>\u201cAmac\u0131m\u0131z, bu tesislerin k\u00fcresel standartlarda \u00e7al\u0131\u015fmas\u0131n\u0131 sa\u011flamak.\u201d<\/strong><\/p>\n<p>BioNTech\u2019in tesiste \u00fcretece\u011fi miktar; <strong>\u00fcretilen mRNA \u00fcr\u00fcn\u00fcn\u00fcn t\u00fcr\u00fcne<\/strong>, <strong>doz ba\u015f\u0131na d\u00fc\u015fen RNA miktar\u0131na<\/strong> ve <strong>\u00fcr\u00fcn\u00fcn form\u00fclasyonuna<\/strong> ba\u011fl\u0131 olacak. \u00d6rne\u011fin, <strong>Pfizer-BioNTech Covid-19 a\u015f\u0131s\u0131na benzer bir RNA s\u00fcrecine sahip bir \u00fcr\u00fcnle<\/strong>, <strong>y\u0131lda 50 milyon doza kadar<\/strong> \u00fcretim yap\u0131labilecek.<\/p>\n<p>A\u00e7\u0131l\u0131\u015fta konu\u015fan <strong>Barbados Ba\u015fbakan\u0131 Mia Mottley<\/strong>,<\/p>\n<p><strong>\u201cBug\u00fcn Afrika halk\u0131, \u00e7ocuklar\u0131 ve yeti\u015fkinleri i\u00e7in somut bir d\u00f6n\u00fcm noktas\u0131n\u0131 temsil ediyor. Bu ad\u0131m yaln\u0131zca pandemilerle m\u00fccadelede de\u011fil, ayn\u0131 zamanda insanlar\u0131m\u0131z\u0131n d\u00fcnyadaki en iyi tedavi ve biyolojik \u00fcr\u00fcnlere eri\u015febilmesi a\u00e7\u0131s\u0131ndan da kritik,\u201d<\/strong> dedi.<\/p>\n<p><strong>Avrupa Komisyonu Ba\u015fkan\u0131 Ursula von der Leyen<\/strong> ise, <strong>Covid-19 pandemisi s\u0131ras\u0131nda ya\u015fanan a\u015f\u0131 e\u015fitsizli\u011fine<\/strong> dikkat \u00e7ekerek \u015funlar\u0131 s\u00f6yledi:<\/p>\n<p><strong>\u201cMilyarlarca insan a\u015f\u0131ya ihtiya\u00e7 duyuyordu, ancak yaln\u0131zca birka\u00e7 tesis \u00fcretim yapabiliyordu. Bu nedenle Ruanda ve Avrupa\u2019n\u0131n, yaln\u0131zca Afrika\u2019ya a\u015f\u0131 getirmek i\u00e7in de\u011fil, a\u015f\u0131 \u00fcretimini ve mRNA teknolojisini Afrika\u2019ya ta\u015f\u0131mak i\u00e7in birlikte \u00e7al\u0131\u015fmas\u0131 gerekti\u011fi konusunda mutab\u0131k kald\u0131k.\u201d<\/strong><\/p>\n<p>Von der Leyen, bu tesisin <strong>Afrika ve Avrupa aras\u0131nda<\/strong>, <strong>bilim insanlar\u0131, yenilik\u00e7i \u015firketler, h\u00fck\u00fcmetler, finans ve d\u00fczenleyici kurumlar aras\u0131nda bir ekip \u00e7al\u0131\u015fmas\u0131n\u0131n \u00fcr\u00fcn\u00fc<\/strong> oldu\u011funu vurgulad\u0131.<\/p>\n<p>A\u00e7\u0131l\u0131\u015fa ayr\u0131ca <strong>Senegal Cumhurba\u015fkan\u0131 Macky Sall<\/strong>, <strong>Gana Cumhurba\u015fkan\u0131 Nana Akufo-Addo<\/strong> ve di\u011fer liderler de kat\u0131ld\u0131.<\/p>\n<p>BioNTech, <strong>2024 y\u0131l\u0131nda Afrika\u2019da s\u0131tma, t\u00fcberk\u00fcloz ve HIV\u2019e y\u00f6nelik a\u015f\u0131 adaylar\u0131 i\u00e7in klinik denemeler<\/strong> y\u00fcr\u00fctmeyi planl\u0131yor. Bu hastal\u0131klar Afrika\u2019da yayg\u0131n olup, <strong>her y\u0131l iki milyondan fazla \u00f6l\u00fcme<\/strong>, \u00f6zellikle de <strong>\u00e7ocuk \u00f6l\u00fcmlerine<\/strong> ciddi \u00f6l\u00e7\u00fcde katk\u0131da bulunuyor.<\/p>\n<p><strong>Bu a\u015f\u0131lar\u0131n ba\u015far\u0131yla geli\u015ftirilip onaylanmas\u0131 halinde<\/strong>, BioNTech, <strong>d\u00fc\u015f\u00fck gelirli \u00fclkelere bu a\u015f\u0131lar\u0131 k\u00e2r amac\u0131 g\u00fctmeden sunmay\u0131<\/strong> hedefliyor.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Alman biyoteknoloji \u015firketi BioNTech, 18 Aral\u0131k Pazartesi g\u00fcn\u00fc, mRNA a\u015f\u0131lar\u0131n\u0131n \u00fcretimini kolayla\u015ft\u0131rma \u00e7abalar\u0131n\u0131n bir par\u00e7as\u0131 olarak Afrika\u2019daki ilk tesisini Ruanda\u2019n\u0131n ba\u015fkenti Kigali\u2019de hizmete a\u00e7t\u0131. Kigali \u00d6zel Ekonomik B\u00f6lgesi\u2019nde, Gasabo B\u00f6lgesi s\u0131n\u0131rlar\u0131 i\u00e7inde, biyofarmas\u00f6tik \u00fcretime ayr\u0131lm\u0131\u015f bir alanda yer alan tesis, yakla\u015f\u0131k 300.000 metrekarelik bir alan\u0131 kaps\u0131yor. Tam kapasiteye ula\u015ft\u0131\u011f\u0131nda en az 100 ki\u015fiye istihdam sa\u011flayacak. &hellip; <a href=\"https:\/\/www.sutyo.com\/tr\/ruanda-biontechin-afrikadaki-ilk-asi-uretim-tesisini-acti\/\" class=\"more-link\">Okumaya devam et<span class=\"screen-reader-text\"> &#8220;Ruanda, Biontech\u2019in Afrika\u2019daki \u0130lk A\u015f\u0131 \u00dcretim Tesisini A\u00e7t\u0131&#8221;<\/span><\/a><\/p>","protected":false},"author":1271,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[393],"tags":[],"class_list":["post-5769","post","type-post","status-publish","format-standard","hentry","category-hayvancilik"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/posts\/5769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/users\/1271"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/comments?post=5769"}],"version-history":[{"count":0,"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/posts\/5769\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/media?parent=5769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/categories?post=5769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sutyo.com\/tr\/wp-json\/wp\/v2\/tags?post=5769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}